Brian Marckx, CFA
This morning SANUWAVE Health (SNWV) announced that additional data from a clinical trial comparing dermaPACE to hyperbaric oxygen therapy (HBOT) was published in the online edition of Diabetes Research and Clinical Practice.  Data from the initial study titled, Treatment of Diabetic Foot Ulcers: A Comparative Study of Extracorporeal Shockwave Therapy and Hyperbaric Oxygen Therapy, revealed that dermaPACE was more effective than HBOT in healing diabetic foot ulcers … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards